Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma Lenalidomide has been shown to have single agent activity in indolent Non-Hodgkin's Lymphoma. It is approved for the treatment of multiple myeloma and myelodysplastic syndrome. Rituximab ...

• Country None
• organs None
• Specialty None

Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia The purpose of this study is to determine whether bortezomib in combination with doxil/lipodox is effective in the treatment of Acute Myeloid Leukemia.

• Country United States
• organs None
• Specialty None

Ofatumumab and Fresh Frozen Plasma in Patients With Chronic Lymphocytic Lymphoma It has been shown that many patients with lymphoma or chronic lymphocytic leukemia (CLL)have low levels of complement. Several drugs have been approved by the Food and Drug Administration ...

• Country None
• organs None
• Specialty None